Crafton Biotechnology
Startup
Crafton Biotechnology is a privately-held mRNA drug developer with a pipeline of novel mRNA vaccines and therapeutics, powered by our suite of novel platform technologies including PureCap®, and chemical synthesis of mRNA. PureCap is the world's first Cap2, that allows for production of extremely pure capped mRNA, with higher protein expression, and lower immunogenicity compared to current gold standard. Our first asset for COVID enters the clinic in 2026, and we have programs on in vivo CAR, solid tumors and others.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events